Dutch Supreme Court Sustains Immunomedics Patent
The court held that Immunomedics' Dutch patent for highly specific monoclonal antibodies against the cancer marker, carcinoembryonic antigen, was valid. The German Patent Court also had held earlier that the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login